
Child and Adolescent Psychiatrist

No OPD information available
Attention Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder
Bipolar Disorder (BPD)
Cerebral Palsy
COVID-19
Drug Induced Dyskinesia
Major Depression
Movement Disorders
Neurofibromatosis
Neurofibromatosis Type 1 (NF1)
Obsessive-Compulsive Disorder (OCD)
Pneumonia
Prader-Willi Syndrome
Severe Acute Respiratory Syndrome (SARS)
Small for Gestational Age
David R. Coghill is a male medical professional who helps people with different health conditions like ADHD, Autism, Bipolar Disorder, Cerebral Palsy, and more. He also works with patients who have illnesses such as COVID-19, Pneumonia, and SARS.
David R. Coghill uses special skills and treatments to help his patients feel better. He talks to his patients in a way that makes them feel comfortable and safe. Patients trust him because he listens to their concerns and explains things clearly.
David R. Coghill stays updated with the latest medical knowledge and research to provide the best care for his patients. He works closely with other medical professionals to learn new things and improve patient care.
David R. Coghill has good relationships with his colleagues, and they work together to help patients. His work has made a positive impact on many people's lives by improving their health and well-being.
One of David R. Coghill's notable publications is "Establishing the Research Priorities of ADHD Professionals: An International Delphi Study." This shows that he is dedicated to advancing medical knowledge in his field.
He also conducted a clinical trial called "A Phase 4, Open-Label, Multicentre, Safety Study of Lisdexamfetamine Dimesylate in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)." This study aimed to improve treatments for ADHD in young people.
In summary, David R. Coghill is a caring and knowledgeable medical professional who works hard to help his patients and contribute to medical research. His dedication to improving healthcare and his positive impact on patients' lives make him a respected and valuable member of the medical community.
Enrollment Status: Completed
Published: June 10, 2021
Intervention Type: Drug
Study Drug:
Study Phase: Phase 4
